- Home
- PINE vs ALEC Comparison
PINE vs ALEC Comparison
Compare PINE & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PINE | ALEC |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.5M | 245.4M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PINE | ALEC |
|---|---|---|
| Price | $20.08 | $1.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $20.10 | $4.83 |
| AVG Volume (30 Days) | 136.0K | ★ 703.1K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 6.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $60,532,000.00 | $21,045,000.00 |
| Revenue This Year | $18.63 | $2.03 |
| Revenue Next Year | N/A | $29.87 |
| P/E Ratio | $333.00 | ★ N/A |
| Revenue Growth | ★ 15.90 | N/A |
| 52 Week Low | $13.10 | $1.09 |
| 52 Week High | $20.80 | $3.40 |
Technical Indicators
Market Signals| Indicator | PINE | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 57.80 | 27.19 |
| Support Level | $18.80 | $1.14 |
| Resistance Level | $20.80 | $1.60 |
| Average True Range (ATR) | 0.43 | 0.15 |
| MACD | 0.07 | -0.04 |
| Stochastic Oscillator | 76.95 | 10.71 |
Price Performance
Historical ComparisonAbout PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.